nicotine has been researched along with astressin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruijnzeel, AW; Isaac, S; Prado, M | 1 |
Aimiuwu, O; Friedman, TC; Gomez, R; Liu, Y; Lutfy, K; Mangubat, M; Nerio, N; Shin, CS | 1 |
Bagosi, Z; Balangó, B; Bokor, P; Buzás, A; Csabafi, K; Palotai, M; Pintér, D; Simon, B; Szabó, G; Telegdy, G | 1 |
3 other study(ies) available for nicotine and astressin
Article | Year |
---|---|
Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
Topics: Animals; Benzenesulfonates; Brain; Corticotropin-Releasing Hormone; Extinction, Psychological; Food; Injections, Intraventricular; Male; Nicotine; Peptide Fragments; Psychomotor Performance; Quinolines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Recurrence; Reward; Self Stimulation; Stress, Psychological; Substance Withdrawal Syndrome | 2009 |
Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors.
Topics: Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Drug Interactions; Indoles; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Peptide Fragments; Pyrimidines; Pyrroles; Pyrrolidines; Receptors, Corticotropin-Releasing Hormone; Receptors, Vasopressin | 2012 |
Changes in striatal dopamine release and locomotor activity following acute withdrawal from chronic nicotine are mediated by CRF1, but not CRF2, receptors.
Topics: Animals; Corpus Striatum; Corticotropin-Releasing Hormone; Dopamine; Dopaminergic Neurons; Locomotion; Male; Motor Activity; Nicotine; Peptide Fragments; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome | 2019 |